0 CHECKOUT

NRT Smoking Cessation Aids in Germany

  • ID: 342835
  • November 2015
  • Region: Germany
  • 21 pages
  • Euromonitor International
1 of 3

As the number of smokers in Germany declined by another 1% in 2015, the potential customer base for NRT smoking cessation aids also continued to decrease. As a result, current value growth continued to slow down, dropping to 1%. The main driver of the increase in 2015 was the innovative Nicorette Spray, which Johnson & Johnson launched in late 2013. The new and convenient format motivated German consumers to try and quit smoking, thereby driving overall growth in the category.

The NRT Smoking Cessation Aids in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown
2 of 3

NRT SMOKING CESSATION AIDS IN GERMANY

November 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2010-2015
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015
Table 4 Sales of NRT Gum by Flavour: % Value 2010-2015
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2011-2015
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2012-2015
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
Executive Summary
Stronger Growth in Consumer Health in 2015
Colds, Influenza and A Gastrointestinal Virus Drive Value Growth
Consumer Health Remains Fragmented, But in Domestic Hands
the Sales of Chemists/pharmacies Grow Through Remote Sales
Opposing Future Trends Expected To Lead To the Balanced Value Development of Consumer Health
Key Trends and Developments
the Reciprocity of Consumer Health and An Ageing Population
in Sickness and in Health - the Impact of Consumers' Lifestyles on Consumer Health
the Risks and Opportunities of the Progression of Digitalisation for Consumer Health
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2010-2015
Table 10 Life Expectancy at Birth 2010-2015
Market Data
Table 11 Sales of Consumer Health by Category: Value 2010-2015
Table 12 Sales of Consumer Health by Category: % Value Growth 2010-2015
Table 13 NBO Company Shares of Consumer Health: % Value 2011-2015
Table 14 LBN Brand Shares of Consumer Health: % Value 2012-2015
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2010-2015
Table 16 Distribution of Consumer Health by Format: % Value 2010-2015
Table 17 Distribution of Consumer Health by Format and Category: % Value 2015
Table 18 Forecast Sales of Consumer Health by Category: Value 2015-2020
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2015-2020
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2013-2015
Sources
Summary 2 Research Sources

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer Inc.
  • Boehringer Ingelheim GmbH